Evidence map›Paper›PMID 39570291›Full record

ArticleJournal of neurophysiology2024

Postsynaptic dopamine D

Kyle A Brown, Michael Stramiello, Jason K Clark, John J Wagner

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kyle A BrownDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, United States.ORCID 0000-0003-1959-6724
Michael StramielloDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, United States.
Jason K ClarkDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, United States.
John J WagnerDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, United States.

Funding

Cocaine-induced Metaplasticity in the HippocampusR01DA016302 · NIDA · UNIVERSITY OF GEORGIA (UGA) · PI WAGNER, JOHN J · 2003 to 2010
$1.1M
HHS | National Institutes of Health (NIH) DA016302NIDA NIH HHS R01 DA016302University of Georgia (UGA) Interdisciplinary Toxicology Program
6 · The paper itself

Abstract

Although the actions of dopamine throughout the brain are clearly linked to motivation and cognition, the specific role(s) of dopamine in the CA1 subfield of the ventral hippocampus (vH) is unresolved. Prior preclinical studies suggest that dopamine D

Indexed as

CA1 Region, HippocampalGABAergic NeuronsPyramidal CellsRats, Sprague-DawleyReceptors, Dopamine D3Receptors, Opioid, muAnimalsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Inhibitory Postsynaptic PotentialsInterneuronsMaleRatsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Receptors, Dopamine D3Receptors, Opioid, mudopamine D3 receptorinterneuronneurogliaform cellventral hippocampusμ-opioid receptor

Identifiers

PMID39570291
PMCPMC11968057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.